|
| |
 |
| |
|
| |
| Latest News |
ImClone Systems Reports First Quarter 2008 Financial Results
>>more
|
ImClone Announces Agreement with FDA on Special Protocol Assessment for Phase III Study of IMC-1121B in Breast Cancer
>>more
|
|
|
|
 |
| |
ImClone Systems Incorporated is a fully integrated global biopharmaceutical company committed to advancing oncology care
by developing and commercializing a portfolio of targeted biologic treatments designed to address the medical needs of patients
with a variety of cancers.
Featured Events
May 15 - 18
SCIENTIFIC CONFERENCE:
ONS Annual Meeting
Philadelphia, PA
>>more
|
May 30 - June 3
SCIENTIFIC CONFERENCE:
ASCO Annual Meeting
Chicago, IL
>>more
|
|
|
